12/16
12:38 pm
kapa
Kairos Pharma to Participate in The Microcap Conference in January 2025 [Yahoo! Finance]
Medium
Report
Kairos Pharma to Participate in The Microcap Conference in January 2025 [Yahoo! Finance]
12/16
12:15 pm
kapa
Kairos Pharma to Participate in The Microcap Conference in January 2025
Low
Report
Kairos Pharma to Participate in The Microcap Conference in January 2025
12/3
08:44 am
kapa
Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial [Yahoo! Finance]
Low
Report
Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial [Yahoo! Finance]
12/3
08:30 am
kapa
Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial
Low
Report
Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial
11/26
08:30 am
kapa
IBN Initiates Coverage of Kairos Pharma Ltd.
Medium
Report
IBN Initiates Coverage of Kairos Pharma Ltd.
11/19
08:41 am
kapa
Kairos Pharma Approved to Dual List on Upstream [Yahoo! Finance]
Medium
Report
Kairos Pharma Approved to Dual List on Upstream [Yahoo! Finance]
11/19
08:30 am
kapa
Kairos Pharma Approved to Dual List on Upstream
Medium
Report
Kairos Pharma Approved to Dual List on Upstream
10/22
09:00 am
kapa
Kairos Pharma to Present at the LD Micro Main Event XVII
Medium
Report
Kairos Pharma to Present at the LD Micro Main Event XVII
10/9
04:30 pm
kapa
Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Low
Report
Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
9/24
04:26 pm
kapa
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients [Yahoo! Finance]
High
Report
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients [Yahoo! Finance]
9/24
04:20 pm
kapa
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
Medium
Report
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients